Managed Access Program for Combination Treatment With Belantamab Mafodotin in Multiple Myeloma
Clinical trial NCT03763370 · AVAILABLE
Trial details
- NCT number
- NCT03763370
- Sponsor
- GlaxoSmithKline
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.